Intrinsic Value of S&P & Nasdaq Contact Us

Deciphera Pharmaceuticals, Inc. DCPH NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
51/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$26.32
+2.9%

Deciphera Pharmaceuticals, Inc. (DCPH) — Analyst outlook / Analyst consensus target is. Based on 26 analyst ratings, the consensus is bullish — 13 Buy, 12 Hold, 1 Sell.

The consensus price target is $26.32 (low: $25.00, high: $30.00), representing an upside of 2.9% from the current price $25.59.

DCPH Stock — 12-Month Price Forecast

$26.32
▲ +2.85% Upside
Average Price Target
Based on 26 Wall Street analysts offering 12-month price targets for Deciphera Pharmaceuticals, Inc., the average price target is $26.32, with a high forecast of $30.00, and a low forecast of $25.00.
The average price target represents a +2.85% change from the last price of $25.59.
Highest Price Target
$30.00
Average Price Target
$26.32
Lowest Price Target
$25.00

DCPH Analyst Ratings

Buy
26
Ratings
13 Buy
12 Hold
1 Sell
Based on 26 analysts giving stock ratings to Deciphera Pharmaceuticals, Inc. in the past 3 months
Rating breakdown
Buy
13 50%
Hold
12 46%
Sell
1 4%
50%
Buy
13 analysts
46%
Hold
12 analysts
4%
Sell
1 analysts
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message